home / stock / abus / abus articles

ABUS Articles, Arbutus Biopharma Corporation - From 11/07/23

Stock Information
Company Name: Arbutus Biopharma Corporation
Stock Symbol: ABUS
Market: NASDAQ
Website: arbutusbio.com
Menu
ABUS ABUS Quote ABUS Short ABUS News ABUS Articles ABUS Message Board
Get ABUS Alerts

News, Short Squeeze, Breakout and More Instantly...
Arbutus Reports Third Quarter 2023 Financial Results and Provides Corporate Update | Benzinga

Multiple data presentations upcoming at AASLD – The Liver Meeting®, including preliminary data from Phase 2a clinical trial combining imdus...
Arbutus Announces CEO, William Collier, to Retire December 31, 2023 | Benzinga

Michael J. McElhaugh, Arbutus Co-founder and COO, to Serve as Interim CEO WARMINSTER, Pa., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma C...

Arbutus to Present at H.C. Wainwright 4th Annual Hepatitis B Virus (HBV) Virtual Conference | Benzinga

WARMINSTER, Pa., Oct. 18, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (NASDAQ:ABUS) ("Arbutus" or the "Company"), a clinical-stage bi...

Arbutus Announces Multiple Abstracts Accepted for Presentation at AASLD - The Liver Meeting® 2023 | Benzinga

Imdusiran data will be highlighted in late breaking presentation WARMINSTER, Pa., Oct. 11, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporatio...
Small Biotech Promosome Drops Lawsuit Against Pfizer, BioNTech in COVID-19 Vaccine Patent Dispute | Benzinga

Biotech firm Promosome has agreed to end the lawsuit, which accused the COVID-19 vaccine manufacturers, Pfizer Inc (NYSE: PFE) ...

Arbutus to Participate in Two Upcoming Investor Conferences | Benzinga

WARMINSTER, Pa., Sept. 07, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (NASDAQ:ABUS), a clinical-stage biopharmaceutical company leve...

Previous 10 Next 10